Citi Maintains 'Buy' on Pediatrix Medical Group (PDX), Drops Price Target
More News related to PDX
- Pediatrix Medical Name Change to MEDNAX Effective Today
- Pediatrix Medical (PDX) Acquires Tampa Bay Maternal Fetal Group Practice
- Wasserman Initiates Coverage on Pediatrix Medical Group (PDX) with a Buy
- Pediatrix Medical (PDX) Reports In-Line Q3; Guides
- Citi Maintains 'Buy' on Pediatrix Medical Group (PDX), Drops Price Target
More News related to Analyst Comments
- Toll (TOL) Reports Preliminary Q4, FY09 Results
- China Digital TV (STV) Misses Q3 EPS by 2c; Guides Below for Q4
- AirMedia Group (AMCN) Tops Q3 EPS by 3c; Guides In-line for Q4
- Maidenform Brands (MFB) Reports Mixed Q3 Earnings; Guides Q4, Raises FY09 Outlook
- Emdeon (EM) Tops Q3 EPS by 2c; Guides In-line for FY09
Citi maintains a 'Buy' on Pediatrix Medical Group Inc (NYSE: PDX), lowers price target from $66 to $55.
Citi analyst says, "PDX lowered 3Q08 EPS guidance by 3-4c (3.5-4.5%) due to adverse payor mix shift that began in August (implies a 100-200bp shift). We believe this mix shift will continue as long as unemployment is rising (particularly CA, FL & TX) and have revised our forward estimates lower to reflect such a trend...We are lowering 2009 from $3.65 to $3.40 to reflect the recent payor mix shift + an additional 100bp deterioration in 2009 and a 2% decline in SS NICU volumes. We believe this constitutes a reasonable worst-case scenario."
Pediatrix Medical Group, Inc. (Pediatrix) is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care.
Related Categories
Analyst CommentsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
